DT
Dermata Therapeutics, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$4.1Msold at filing
Total offering$4.1M
Investors in the raise14count reported to the SEC
FiledJan 7, 2026first sale Dec 29, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Maria J. Bedoya Toro MuneraExecutive Officer
Mary J. FisherDirector
Kathleen J. ScottDirector
Steven J. MentoDirector
Wendell J. WierengaDirector
Gerald ProehlExecutive Officer, Director
Andrew J. SandlerDirector
Kyri K. Van HooseExecutive Officer
David J. HaleDirector
Christopher J. NardoExecutive Officer
Brittany J. BradrickDirector
Executive officers, directors and promoters as listed on the Form D.